Recent treatment modalities for cardiovascular diseases with a focus on stem cells, aptamers, exosomes and nanomedicine
Source abstract
Abstract
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide. Due to the significant impact of CVD on humans, there is a need to develop novel treatment modalities tailored to major classes of cardiac diseases including hypertension, coronary artery disease, cardiomyopathies, arrhythmias, valvular disease and inflammatory diseases. In this article, we discuss recent advancements regarding development of therapeutic strategies based on stem cells, aptamers, exosomes, drug-eluting and dissolvable stents, immunotherapy and nanomedicine for the treatment of CVD. We summarize current research and clinical advances in cardiovascular therapeutics, with a focus on therapies that move beyond current oral- or sublingual-based regimens. This review article provides insight into current research and future treatment strategies that hold a great relevance for future clinical practice in pursuit of improving quality of life of patients suffering from CVD.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Otolaryngology, University of Miami Miller School of Medicine
Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University
Department of Immunology, Center for Personalized Nanomedicine, Herbert Wertheim College of Medicine, Florida International University
Funding
The Campbell Foundation
References (81)
Show source-provided references
1. 10.1007/s11886-017-0917-z10.1007/s11886-017-0917-z ↗
2. 10.1161/CIRCULATIONAHA.116.00873110.1161/CIRCULATIONAHA.116.008731 ↗
3. 10.1016/j.jjcc.2016.12.00610.1016/j.jjcc.2016.12.006 ↗
4. 10.1080/14017431.2017.134627810.1080/14017431.2017.1346278 ↗
5. 10.1161/CIRCRESAHA.115.30816510.1161/CIRCRESAHA.115.308165 ↗
6. 10.1161/CIRCRESAHA.117.31146610.1161/CIRCRESAHA.117.311466 ↗
7. Perin EC. Stem cell therapy for cardiovascular disease. Tex Heart Inst J. 2006;33:204.
8. 10.1002/term.710.1002/term.7 ↗
9. 10.1161/01.cir.0000032889.55215.f110.1161/01.cir.0000032889.55215.f1 ↗
10. 10.1001/archinte.167.10.98910.1001/archinte.167.10.989 ↗
11. 10.1093/eurjhf/hfq09510.1093/eurjhf/hfq095 ↗
12. 10.1093/eurheartj/ehl38810.1093/eurheartj/ehl388 ↗
13. 10.1016/j.ijcard.2007.04.09810.1016/j.ijcard.2007.04.098 ↗
14. 10.1016/j.jacc.2013.02.07110.1016/j.jacc.2013.02.071 ↗
15. 10.1097/MOT.0b013e32830fdfc410.1097/MOT.0b013e32830fdfc4 ↗
16. 10.1016/j.scr.2009.12.00310.1016/j.scr.2009.12.003 ↗
17. 10.1161/circ.100.suppl_2.Ii-24710.1161/circ.100.suppl_2.Ii-247 ↗
18. 10.1002/jgm.299510.1002/jgm.2995 ↗
19. 10.1016/S0092-8674(03)00687-110.1016/S0092-8674(03)00687-1 ↗
20. 10.1016/j.stem.2012.02.00510.1016/j.stem.2012.02.005 ↗
21. 10.1038/nature0321510.1038/nature03215 ↗
22. 10.1073/pnas.213212610010.1073/pnas.2132126100 ↗
23. 10.1007/s00395-009-0065-810.1007/s00395-009-0065-8 ↗
24. 10.4103/2045-8932.9760310.4103/2045-8932.97603 ↗
25. 10.1152/ajpheart.00590.200910.1152/ajpheart.00590.2009 ↗
26. 10.1016/j.yjmcc.2010.08.00510.1016/j.yjmcc.2010.08.005 ↗
27. 10.1016/j.stem.2009.02.00110.1016/j.stem.2009.02.001 ↗
28. 10.1161/CIRCRESAHA.111.24314710.1161/CIRCRESAHA.111.243147 ↗
29. 10.1038/nature0680010.1038/nature06800 ↗
30. 10.1016/j.stem.2012.10.01010.1016/j.stem.2012.10.010 ↗
31. 10.1161/01.CIR.0000027585.05868.6710.1161/01.CIR.0000027585.05868.67 ↗
32. 10.1161/CIRCULATIONAHA.112.00057010.1161/CIRCULATIONAHA.112.000570 ↗
33. 10.1016/j.thromres.2014.05.02110.1016/j.thromres.2014.05.021 ↗
34. 10.2174/09298671179718967310.2174/092986711797189673 ↗
35. 10.1097/MBC.000000000000007810.1097/MBC.0000000000000078 ↗
36. 10.1161/CIRCRESAHA.111.25566110.1161/CIRCRESAHA.111.255661 ↗
37. 10.1161/CIRCRESAHA.111.25384910.1161/CIRCRESAHA.111.253849 ↗
38. 10.1001/jama.2016.611010.1001/jama.2016.6110 ↗
39. 10.1007/s10741-014-9469-010.1007/s10741-014-9469-0 ↗
40. 10.1016/j.vph.2015.02.00810.1016/j.vph.2015.02.008 ↗
41. 10.3389/fphys.2017.0049410.3389/fphys.2017.00494 ↗
42. 10.1038/sj.leu.240429610.1038/sj.leu.2404296 ↗
43. 10.1093/cvr/cvu16710.1093/cvr/cvu167 ↗
44. 10.1016/j.jacc.2015.02.02610.1016/j.jacc.2015.02.026 ↗
45. 10.1093/eurheartj/ehw11310.1093/eurheartj/ehw113 ↗
46. 10.1007/s10557-016-6698-610.1007/s10557-016-6698-6 ↗
47. Garcia-Garcia HM, Vaina S, Tsuchida K, et al. Drug-eluting stents. Arch Cardiol Mex. 2006;76:297–319.
48. 10.1161/01.CIR.102.4.39910.1161/01.CIR.102.4.399 ↗
49. 10.1016/j.tem.2012.10.00810.1016/j.tem.2012.10.008 ↗
50. 10.1016/j.ahj.2013.07.01010.1016/j.ahj.2013.07.010 ↗
51. 10.1093/rheumatology/kep36610.1093/rheumatology/kep366 ↗
52. 10.1002/acr.2037110.1002/acr.20371 ↗
53. 10.1038/cti.2016.3110.1038/cti.2016.31 ↗
54. 10.1093/rheumatology/keu22410.1093/rheumatology/keu224 ↗
55. 10.1002/smll.20080080610.1002/smll.200800806 ↗
56. 10.1021/nl103812a10.1021/nl103812a ↗
57. 10.1016/j.chembiol.2004.11.02010.1016/j.chembiol.2004.11.020 ↗
58. 10.7150/thno.768810.7150/thno.7688 ↗
59. 10.3390/md1304181910.3390/md13041819 ↗
60. 10.1016/j.ijpharm.2005.12.03810.1016/j.ijpharm.2005.12.038 ↗
61. 10.1016/j.biomaterials.2007.09.02710.1016/j.biomaterials.2007.09.027 ↗
62. 10.1021/ar200084x10.1021/ar200084x ↗
63. 10.2217/nnm.11.17910.2217/nnm.11.179 ↗
64. 10.1016/j.biomaterials.2009.06.00610.1016/j.biomaterials.2009.06.006 ↗
65. 10.1002/smll.20100059610.1002/smll.201000596 ↗
66. 10.1161/CIRCULATIONAHA.113.00287010.1161/CIRCULATIONAHA.113.002870 ↗
67. 10.5551/jat.3511310.5551/jat.35113 ↗
68. 10.1161/01.CIR.0000068315.98705.CC10.1161/01.CIR.0000068315.98705.CC ↗
69. 10.1161/01.STR.0000131268.50418.b710.1161/01.STR.0000131268.50418.b7 ↗
70. 10.1021/acsnano.7b0230810.1021/acsnano.7b02308 ↗
71. 10.2147/IJN.S13194910.2147/IJN.S131949 ↗
72. 10.1371/journal.pone.013245110.1371/journal.pone.0132451 ↗
73. 10.7150/thno.721010.7150/thno.7210 ↗
74. 10.1155/2012/19370410.1155/2012/193704 ↗
75. 10.1111/j.1755-5922.2012.00317.x10.1111/j.1755-5922.2012.00317.x ↗
76. 10.1016/j.jconrel.2013.04.02210.1016/j.jconrel.2013.04.022 ↗
77. 10.1007/s12265-011-9292-010.1007/s12265-011-9292-0 ↗
78. 10.1016/j.biomaterials.2013.06.05110.1016/j.biomaterials.2013.06.051 ↗
79. 10.1161/01.CIR.92.4.93510.1161/01.CIR.92.4.935 ↗
80. 10.1007/s11095-005-8354-x10.1007/s11095-005-8354-x ↗
81. 10.1096/fj.08-12737310.1096/fj.08-127373 ↗